ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

apotex nz ltd - olanzapine 2.5mg - film coated tablet - 2.5 mg - active: olanzapine 2.5mg excipient: hyprolose hypromellose lactose monohydrate macrogol 8000 magnesium stearate maize starch microcrystalline cellulose purified water titanium dioxide - olanzapine is indicated for the treatment of schizophrenia and related psychoses.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

apotex nz ltd - olanzapine 20mg - film coated tablet - 20 mg - active: olanzapine 20mg excipient: hyprolose hypromellose iron oxide red iron oxide yellow lactose monohydrate macrogol 8000 magnesium stearate maize starch microcrystalline cellulose purified water titanium dioxide - olanzapine is indicated for the treatment of schizophrenia and related psychoses.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

apotex nz ltd - olanzapine 5mg - film coated tablet - 5 mg - active: olanzapine 5mg excipient: hyprolose hypromellose lactose monohydrate macrogol 8000 magnesium stearate maize starch microcrystalline cellulose purified water titanium dioxide - olanzapine is indicated for the treatment of schizophrenia and related psychoses.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

apotex nz ltd - olanzapine 7.5mg - film coated tablet - 7.5 mg - active: olanzapine 7.5mg excipient: hyprolose hypromellose lactose monohydrate macrogol 8000 magnesium stearate maize starch microcrystalline cellulose purified water titanium dioxide - olanzapine is indicated for the treatment of schizophrenia and related psychoses.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

apotex nz ltd - olanzapine 10mg - orodispersible tablet - 10 mg - active: olanzapine 10mg excipient: carmellose calcium colloidal silicon dioxide magnesium stearate mannitol microcrystalline cellulose sucralose - olanzapine is indicated for the treatment of schizophrenia and related psychoses.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

apotex nz ltd - olanzapine 15mg - orodispersible tablet - 15 mg - active: olanzapine 15mg excipient: carmellose calcium colloidal silicon dioxide magnesium stearate mannitol microcrystalline cellulose sucralose - olanzapine is indicated for the treatment of schizophrenia and related psychoses.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

apotex nz ltd - olanzapine 20mg - orodispersible tablet - 20 mg - active: olanzapine 20mg excipient: carmellose calcium colloidal silicon dioxide magnesium stearate mannitol microcrystalline cellulose sucralose - olanzapine is indicated for the treatment of schizophrenia and related psychoses.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

apotex nz ltd - olanzapine 5mg - orodispersible tablet - 5 mg - active: olanzapine 5mg excipient: carmellose calcium colloidal silicon dioxide magnesium stearate mannitol microcrystalline cellulose sucralose - olanzapine is indicated for the treatment of schizophrenia and related psychoses.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

apotex nz ltd - oxybutynin hydrochloride 1 mg/ml;   - syrup - 1 mg/ml - active: oxybutynin hydrochloride 1 mg/ml   excipient: berry flavour (mix) 538632 citric acid monohydrate fast green fcf glycerol methyl hydroxybenzoate purified water sodium citrate dihydrate sorbitol as 70% solution, 366 mg/ml sucrose - oxybutynin chloride is indicated in adults and children over 5 years of age for the management of urgency and incontinence that characterise neurogenic bladder disorders and idiopathic destrusor instability.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

apotex nz ltd - amlodipine besilate 14mg equivalent to to 10 mg amlodipine;   - tablet - 10 mg - active: amlodipine besilate 14mg equivalent to to 10 mg amlodipine   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - apo-amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent, or an angiotensin-converting enzyme inhibitor. apo-amlodipine is indicated for the first line treatment of myocardial ischaemia, whether due to fixed obstruction (stable angina) and/or vasospasm/vasoconstriction (prinzmetal's or variant angina) of coronary vasculature. amlodipine may be used where the clinical presentation suggests a possible vasospastic/vasoconstrictive component but where vasospasm/vasoconstriction has not been confirmed. apo-amlodipine may be used alone as monotherapy, or in combination with other antianginal drugs in patients with angina that is refractory to nitrates and/or beta blockers.